Semax 10mg

THIS PRODUCT IS INTEDED AS A RESEARCH CHEMICAL ONLY.
This designation allows the use of research chemicals strictly in vitro for testing and laboratory experimentation only. All products information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professional. This product is not a drug, food or cosmetic and may not be misbranded, misused or mislabled as a drug food or cosmetic.

What is Semax?

Semax is a synthetic heptapeptide derivative of adrenocorticotropic hormone (ACTH), comprising amino acids 4 through 10 of the naturally occurring ACTH sequence. Originally developed in Russia, Semax has been investigated extensively in laboratory settings for its potential interactions with the central nervous system, particularly in contexts involving stroke, cognitive impairment, neurological injury, and neuroplasticity.

The peptide consists of the core amino acid sequence Met-Glu-His-Phe, derived from ACTH fragments, with a Pro-Gly-Pro (PGP) tripeptide extension at the C-terminal end. This structural modification is hypothesized to enhance lipophilicity, potentially facilitating passive diffusion across the blood-brain barrier through mechanisms such as lipid raft-mediated endocytosis. Additionally, the acetylation of Semax may confer increased molecular stability, rendering the peptide more resistant to enzymatic degradation and extending its half-life in biological systems.

Research suggests that Semax may modulate the expression of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in the central nervous system, with downstream implications for serotonin and dopamine pathways. The peptide has also been studied for its potential to inhibit enkephalin-degrading enzymes, thereby influencing opioid and neurotransmitter signaling.

Semax Structure

The architecture of this peptide, like that of a well-constructed sentence, reveals its elegance through precision:

Sequence: Ac-Met-Glu-His-Phe-Pro-Gly-Pro
Molecular Formula: C₃₉H₅₄N₁₀O₁₀S
Molecular Weight: 854.99 g/mol
PubChem CID: 122178
CAS Number: 80714-61-0
Synonyms: Pro-Gly-Pro-ACTH, ACTH(4-7)PGP, HY-P1146

The N-acetyl modification affixed to its structure contributes materially to stability and resistance against enzymatic breakdown—characteristics of the utmost consequence for the sustenance of biological activity within experimental systems.

Semax Research
Semax Affects Resting Brain Structure

One observes, through functional magnetic resonance imaging of considerable sophistication, that Semax modulates activity within what scholars denominate the default mode network—a constellation of brain regions exhibiting greater activation during repose than during active task performance. This network comprises neural circuits believed to perform roles most essential: those of social cognition, environmental monitoring, and the capacity to transition from resting states to focused attentiveness.

Research published in the Bulletin of Experimental Biology and Medicine demonstrated, with commendable precision, that intranasal application of Semax (at the modest total dose of 1.2 mg) increased resting fMRI signal in the default mode network's rostral subcomponent relative to placebo in healthy human subjects. By enhancing activity in this network, Semax appears to increase baseline arousal during rest, rendering one more attentive to environmental stimuli—particularly those involving social contexts.

This effect may contribute to enhanced focus and attention observed in behavioural assessments of considerable merit. Increased default mode network connectivity correlates generally with enhanced interconnectivity between various brain regions—a phenomenon most agreeable to improved problem-solving capacity, memory consolidation, and creative thinking in research models. Though direct evidence remains limited, these connectivity patterns suggest that Semax may influence global brain function through modulation of fundamental environmental monitoring systems.

Semax in the Setting of Stroke

In Russia, where scientific rigour has long been held in the highest esteem, Semax has been the subject of investigation as a matter worthy of consideration in cases of acute cerebral hypoxia arising from cerebrovascular incident or traumatic injury to the brain. Experimental research conducted in the laboratory rat has revealed that Semax stimulates molecular mechanisms engaged in the transcription of genes within the central nervous system, modulating with particular effect the expression of twenty-four genes associated with vascular function, the migration of smooth muscle cells, the formation of blood corpuscles, and the generation of new blood vessels.

These molecular alterations are hypothesized to underlie the neuroprotective properties observed in models of stroke, wherein Semax appears to promote the survival of neural tissue, stabilize the function of cellular energy-producing structures, and facilitate the distribution of vital nutrients to cerebral tissue. Clinical investigations of rehabilitation, undertaken principally in Russia, have advanced the supposition that the timely administration of Semax may accelerate the restoration of function and enhance motor performance in the aftermath of ischemic stroke. In the considered judgement of Gusev and his colleagues, "early rehabilitation and administration of Semax increase BDNF plasma levels, speed functional recovery, and improve motor performance".

The capacity of this peptide to stimulate BDNF—a substance of natural origin engaged in the processes of learning and remembrance—may enliven neuroplasticity, enabling the undamaged portions of the brain to assume functions that have been compromised by injury.

Semax and Gene Expression in the Brain

The influence of Semax upon the expression of genes extends beyond the immediate circumstances of acute injury. A single intranasal administration of this compound in healthy laboratory rats has demonstrated its capacity to modulate gene expression within both the hippocampus and the frontal cortex—alterations that manifest themselves within a period of mere minutes. The hippocampus, that most consequential region, bears responsibility for the formation of memory and the acquisition of knowledge, whilst the frontal cortex exercises governance over concentration, the faculty of planning, and the systematic organization of information. Semax demonstrates particularly efficacious effects upon the expression of NGF and BDNF, both substances of the neurotrophic variety, implicated in the growth of nerve cells, their continued existence, and the remarkable plasticity of synaptic connections.

These findings intimate that Semax may exercise considerable influence over the fundamental processes that underlie cognition, thereby opening avenues of investigation into the mechanisms by which learning occurs, information is processed, and cognitive capacity itself may be advanced in research settings.

Semax and Cognitive Performance: A Question of Refinement

Adrenocorticotropic hormone—that natural protein from which Semax is derived—has been the subject of investigation for its potential to preserve the faculties of learning and memory in laboratory models of a neurological disorder most troublesome. ACTH has long commanded the regard of those who study disorders of the nervous system and is held in consideration as a foremost candidate in investigations concerning developmental compromise or regression.

Investigation suggests that Semax, as a synthetic derivative refined from the natural peptide, may offer enhanced stability and efficacy in comparison to its parent compound. Preliminary studies intimate that even diminutive doses of ACTH may prevent the loss of cognitive function in models of seizure, advancing the proposition that this substance may possess qualities most conducive to the augmentation of the intellect—qualities that could extend beyond the particular circumstances of illness. The most thoughtful researchers speculate that Semax may not merely offset cognitive deficits associated with neurological compromise but may serve, under conditions of regular administration at judicious doses within experimental protocols, to elevate cognitive performance above its baseline state.

Semax and Depression

Research in rodent models has demonstrated relationships between BDNF levels and brain function regulation in depressive states—a matter of some consequence to those occupied with such concerns. Current antidepressant medications, whilst efficacious, tend to require several weeks before effects manifest, presenting a conceptual challenge to researchers possessed of scientific rigor.

Emerging evidence suggests that the therapeutic efficacy of such medications may relate to their capacity to increase BDNF levels and thereby stimulate neurogenesis in neural tissues. If this mechanism proves accurate—and preliminary investigations suggest promise—it offers an entirely novel framework for understanding depression and its treatment. Researchers have posited that combining BDNF stimulators such as Semax with such treatments could potentially improve efficacy, though substantial additional investigation remains requisite.

Studies examining chronic unpredictable stress in male Sprague-Dawley rats found that chronic treatment with Semax reversed or substantially attenuated stress-induced anhedonia and decreases in hippocampal BDNF levels—outcomes of particular interest to those studying such phenomena. The peptide exerted effects that appeared temporally stable, with reduction in anxiety-related behaviours sustained from adolescence through young adulthood.

Feature Bullets

• Synthetic ACTH Analog of Merit – Heptapeptide derived from adrenocorticotropic hormone fragment 4-10, extended through Pro-Gly-Pro C-terminal augmentation for enhanced metabolic stability
• Purity of Distinction – Supplied at 99% purity as determined by analytical HPLC, satisfactory to the most rigorous laboratory investigations
• Neurotrophin Modulation – Investigated for effects upon BDNF and NGF gene expression in hippocampal and cortical tissues in experimental models of considerable refinement
• Gene Expression Studies – Examined for influence upon transcriptional regulation and neurotransmitter system genes in central nervous system tissues
• Lyophilized Format – Provided as stable lyophilized powder ensuring long-term stability during storage and transport with commendable reliability
• Cerebrovascular Research Applications – Examined in preclinical models of cerebral ischemia and vascular system function with effects most promising
• Default Mode Network Investigation – Investigated for effects upon resting brain network connectivity and cognitive monitoring systems

Technical Specifications